Ï㽶ÊÓƵ

Krow Ampofo
No Rating Available
(Learn About Our Rating System)

Krow Ampofo, MBChB

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

  • Dr. Krow Ampofo received his medical degree from the Ï㽶ÊÓƵ of Ghana Medical School, completed his pediatric residency at the Children's Hospital of New Jersey at Newark Beth Israel Medical Center, and his fellowship in pediatric infectious diseases at Columbia Ï㽶ÊÓƵ College of Physicians and Surgeons. He is currently a Professor in the Divisions of Pediatric Infectious Diseases at the Ï㽶ÊÓƵ of Utah and Primary Children´s Hospital. Dr. Ampofo´s clinical interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections. He is also keenly interested in the evaluation of internationally adopted children, and tuberculosis in children.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

  • Dr. Krow Ampofo received his medical degree from the Ï㽶ÊÓƵ of Ghana Medical School, completed his pediatric residency at the Children's Hospital of New Jersey at Newark Beth Israel Medical Center, and his fellowship in pediatric infectious diseases at Columbia Ï㽶ÊÓƵ College of Physicians and Surgeons. He is currently a Professor in the Divisions of Pediatric Infectious Diseases at the Ï㽶ÊÓƵ of Utah and Primary Children´s Hospital. Dr. Ampofo´s clinical interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections. He is also keenly interested in the evaluation of internationally adopted children, and tuberculosis in children.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Infectious Diseases
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

    Education history

    Fellowship Pediatric Infectious Diseases - Columbia Ï㽶ÊÓƵ- Children's Hospital of New York/ Columbia Ï㽶ÊÓƵ College of Physicians and Fellow
    Residency Pediatrics - Newark Beth Israel Medical Center Resident
    Internship Pediatrics - Newark Beth Israel Medical Center Intern
    Professional Medical Medicine - Ï㽶ÊÓƵ of Ghana M.B.B.Ch.

    Selected Publications

    Journal Article

    1. Sartori LF, Nian H, Zhu Y, Johnson J, Stassun J, Ampofo K, Arnold DH, Antoon JW, Pavia AT, Grijalva CG, Williams DJ (2025). Removal of Race and White Blood Cell Count in an Updated Pediatric Pneumonia Severity Model. Hosp Pediatr, 14(3), e167-e169. ()
    2. Arnold SR, Jain S, Dansie D, Kan H, Williams DJ, Ampofo K, Anderson EJ, Grijalva CG, Bramley AM, Pavia AT, Edwards KM, Nolan VG, McCullers JA, Kaufman RA (2023). Association of Radiology Findings with Etiology of Community Acquired Pneumonia among Children. J Pediatr, 261, 113333. ()
    3. Suarez D, Nielson C, McVicar SB, Sidesinger M, Ostrander B, OBrien E, Ampofo K, Ling CY, Miner LJ, Park AH (2023). Analysis of an Expanded Targeted Early Cytomegalovirus Testing Program. Otolaryngol Head Neck Surg, 169(3), 679-686. ()
    4. Antoon JW, Nian H, Ampofo K, Zhu Y, Sartori LF, Johnson J, Arnold DH, Stassun J, Pavia AT, Grijalva CG, Williams DJ (2022). Validation of Childhood Pneumonia Prognostic Models for Use in Emergency Care Settings. J Pediatric Infect Dis Soc, 12(8), 451-458. ()
    5. Williams DJ, Martin JM, Nian H, Weitkamp AO, Slagle J, Turer RW, Suresh S, Johnson J, Stassun J, Just SL, Reale C, Beebe R, Arnold DH, Antoon JW, Rixe NS, Sartori LF, Freundlich RE, Ampofo K, Pavia AT, Smith JC, Weinger MB, Zhu Y, Grijalva CG (2023). Antibiotic clinical decision support for pneumonia in the ED: A randomized trial. J Hosp Med, 18(6), 491-501. ()
    6. Lee J, Zhu Y, Williams DJ, Self WH, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Jain S, Edwards KM, Grijalva CG (2022). Red Blood Cell Distribution Width and Pediatric Community-Acquired Pneumonia Disease Severity. Hosp Pediatr, 12(9), 798-805. ()
    7. Greene C, Nian H, Zhu Y, Antoon JW, Freundlich KL, Ampofo K, Sartori LF, Johnson J, Arnold DH, Gesteland P, Stassun J, Robison J, Pavia AT, Grijalva CG, Williams DJ (2022). Associations between comorbidity-related functional limitations and pneumonia outcomes. J Hosp Med, 17(7), 527-533. ()
    8. Sekmen M, Johnson J, Zhu Y, Sartori LF, Grijalva CG, Stassun J, Arnold DH, Ampofo K, Robison J, Gesteland PH, Pavia AT, Williams DJ (2022). Association Between Procalcitonin and Antibiotics in Children With Community-Acquired Pneumonia. Hosp Pediatr, 12(4), 384-391. ()
    9. Ko ER, Henao R, Frankey K, Petzold EA, Isner PD, Jaehne AK, Allen N, Gardner-Gray J, Hurst G, Pflaum-Carlson J, Jayaprakash N, Rivers EP, Wang H, Ugalde I, Amanullah S, Mercurio L, Chun TH, May L, Hickey RW, Lazarus JE, Gunaratne SH, Pallin DJ, Jambaulikar G, Huckins DS, Ampofo K, Jhaveri R, Jiang Y, Komarow L, Evans SR, Ginsburg GS, Tillekeratne LG, McClain MT, Burke TW, Woods CW, Tsalik EL, Antibacterial Resistance Leadership Group (2022). Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection. JAMA Netw Open, 5(4), e227299. ()
    10. Ekambaram M, Nabower A, Rajbhandari P, Eisenberg J, Goodrich N, Ampofo K, Gollehon NS, Martin KC, Lyden E, Snowden J (2022). Evaluation of Discordant Results Between FilmArray Meningitis/Encephalitis Panel and Conventional Testing in Pediatric Patients: A Multisite Retrospective Cohort Study. J Pediatric Infect Dis Soc. ()
    11. Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacn G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, Len ME, Lepp T, Mackenzie GA, Madarov L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K, The Pserenade Team (2021). Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms, 9(4). ()
    12. Garcia Quesada M, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson ME, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce MG, Camilli R, Chanto Chacn G, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Diawara I, Gierke R, Guevara M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kleynhans J, Kristinsson KG, Ladhani SN, McGeer A, Mwenda JM, Nuorti JP, Oishi K, Ricketson LJ, Sanz JC, Savrasova L, Setchanova LP, Smith A, Valentiner-Branth P, Valenzuela MT, van der Linden M, van Sorge NM, Varon E, Winje BA, Yildirim I, Zintgraff J, Knoll MD, The Pserenade Team (2021). Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms, 9(4). ()
    13. Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Madarov L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K, The Pserenade Team (2021). Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms, 9(4). ()
    14. Sartori LF, Zhu Y, Grijalva CG, Ampofo K, Gesteland P, Johnson J, McHenry R, Arnold DH, Pavia AT, Edwards KM, Williams DJ (2021). Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification. Hosp Pediatr, 11(3), 215-222. ()
    15. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Williams DJ (2019). Clinical Features of Human Metapneumovirus-Associated Community-acquired Pneumonia Hospitalizations. Clin Infect Dis, 72(1), 108-117. ()
    16. Crandall H, Christiansen J, Varghese AA, Russon A, Korgenski EK, Bengtson EK, Dickey M, Killpack J, Knackstedt ED, Daly JA, Ampofo K, Pavia AT, Blaschke AJ (2019). Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children. J Pediatric Infect Dis Soc, 9(6), 650-655. ()
    17. Crandall H, Kapusta A, Killpack J, Heyrend C, Nilsson K, Dickey M, Daly JA, Ampofo K, Pavia AT, Mulvey MA, Yandell M, Hulten KG, Blaschke AJ (2020). Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA. PLoS One, 15(9), e0238991. ()
    18. Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Grijalva CG (2020). Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized with Community-Acquired Pneumonia. Clin Infect Dis, 73, e4433-e4443. ()
    19. Gladstone RA, Lo SW, Goater R, Yeats C, Taylor B, Hadfield J, Lees JA, Croucher NJ, van Tonder AJ, Bentley LJ, Quah FX, Blaschke AJ, Pershing NL, Byington CL, Balaji V, Hryviewicz W, Sigauque B, Ravikumar KL, Almeida SCG, Ochoa TJHo PL, du Plessis M, Ndlangisa KM, Cornick JE, Kwambana-Adams B, Benisty R, Nzenze SA, Madhi SA, Hawkins PA, Pollard AJ, Everett DB, Antonio M, Dagan R, Klugman KP, von Gottberg A, Metcalf BJ, Li Y, Beall BW, McGee L, Breiman RF, Aanensen DM, Bentley SD (2020). The Global Pneumococcal Sequencing Consortium Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. . Microb Comp Genomics.
    20. Blaschke AJ, McKevitt M, Ampofo K, Lewis T, Chai H, Guo Y, Dorsch J, Vanderhoof E, Rosen P, Freimann V, Korgenski EK, Toback S, Chien JW (2018). Midturbinate Swabs Are Comparable to Nasopharyngeal Swabs for Quantitative Detection of Respiratory Syncytial Virus in Infants. J Pediatric Infect Dis Soc, 8(6), 554-558. ()
    21. Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Wunderink RG, Anderson EJ, Bramley AM, Jain S, Williams DJ (2019). Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics, 144(1). ()
    22. Stockmann C, Olson J, Rashid J, Lubsch L, Young DC, Hersh AL, Frymoyer A, Ampofo K, Liu X, Wang Y, Sherwin CMT, Zobell JT (2018). An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus. J Clin Pharmacol, 59(2), 198-205. ()
    23. Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, Arnold SR, Williams DJ, Edwards KM, McCullers JA, Pavia AT, Winchell JM, Schrag SJ, Hicks LA (2018). Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis, 68(1), 5-12. ()
    24. Frush JM, Zhu Y, Edwards KM, Grijalva CG, Thomsen IP, Self WH, Jain S, Anderson EJ, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Williams DJ (2018). Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia. J Hosp Med, 13(12), 848-852. ()
    25. Adler FR, Stockmann C, Ampofo K, Pavia AT, Byington CL (2018). Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure. PLoS One, 13(7), e0199388. ()
    26. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers JA (2018). Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia. J Infect Dis, 218(2), 179-188. ()
    27. Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain S (2018). Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 5(4), ofy061. ()
    28. Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Self WH, Bramley A, Jain S, Pavia AT, Blaschke AJ (2018). Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. J Pediatric Infect Dis Soc, 7(1), 46-53. ()
    29. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers JA (2017). The Etiology and Impact of Co-infections in Children Hospitalized with Community-acquired Pneumonia. . Am J Infect Dis.
    30. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG (2017). Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA Pediatr, 171(12), 1184-1191. ()
    31. Lu X, Schneider E, Jain S, Bramley AM, Hymas W, Stockmann C, Ampofo K, Arnold SR, Williams DJ, Self WH, Patel A, Chappell JD, Grijalva CG, Anderson EJ, Wunderink RG, McCullers JA, Edwards KM, Pavia AT, Erdman DD (2017). Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. J Infect Dis, 216(9), 1104-1111. ()
    32. Schlaberg R, Ampofo K, Tardif KD, Stockmann C, Simmon KE, Hymas W, Flygare S, Kennedy B, Blaschke A, Eilbeck K, Yandell M, McCullers JA, Williams DJ, Edwards K, Arnold SR, Bramley A, Jain S, Pavia AT (2017). Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. J Infect Dis, 216(6), 688-696. ()
    33. Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, Trabue C, Fakhran S, Balk R, McCullers JA, Pavia AT, Edwards KM, Wunderink RG, Jain S, Centers for Disease Control and Prevention Etiology of Pneumonia in the Community EPIC Study Team (2017). Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis, 215(12), 1873-1882. ()
    34. Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, Kennedy B, Voelkerding K, Bramley A, Zhang J, Eilbeck K, Yandell M, Jain S, Pavia AT, Tong S, Ampofo K (2017). Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology. J Infect Dis, 215(9), 1407-1415. ()
    35. Stockmann C, Byington CL, Pavia AT, Ampofo K, Wilkes J, Korgenski EK, Hersh AL (2017). Limited and Variable Use of Antivirals for Children Hospitalized With Influenza. JAMA Pediatr, 171(3), 299-301. ()
    36. Harris AM, Bramley AM, Jain S, Arnold SR, Ampofo K, Self WH, Williams DJ, Anderson EJ, Grijalva CG, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Winchell JM, Hicks LA (2017). Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 4(1), ofx014. ()
    37. Zhang Y, Sakthivel SK, Bramley A, Jain S, Haynes A, Chappell JD, Hymas W, Lenny N, Patel A, Qi C, Ampofo K, Arnold SR, Self WH, Williams DJ, Hillyard D, Anderson EJ, Grijalva CG, Zhu Y, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Erdman DD (2017). Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia. J Clin Microbiol, 55(1), 79-89. ()
    38. Stockmann C, Ampofo K, Pavia AT, Blaschke AJ, Mason EO, Presson AP, Forney LJ, Byington CL (2016). Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis, 63(5), 619-626. ()
    39. Millman AJ, Finelli L, Bramley AM, Peacock G, Williams DJ, Arnold SR, Grijalva CG, Anderson EJ, McCullers JA, Ampofo K, Pavia AT, Edwards KM, Jain S (2016). Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders. J Pediatr, 173, 188-195.e4. ()
    40. Flygare S, Simmon K, Miller C, Qiao Y, Kennedy B, Di Sera T, Graf EH, Tardif KD, Kapusta A, Rynearson S, Stockmann C, Queen K, Tong S, Voelkerding KV, Blaschke A, Byington CL, Jain S, Pavia A, Ampofo K, Eilbeck K, Marth G, Yandell M, Schlaberg R (2016). Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling. Genome Biol, 17(1), 111. ()
    41. Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, Erdman D, Finelli L, Jain S, Edwards KM, Grijalva CG (2016). Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis, 213(4), 584-91. ()
    42. Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, Pavia AT, Byington CL (2016). Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine, 34(4), 474-478. ()
    43. Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL (2015). Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hosp Pediatr, 5(12), 605-12. ()
    44. Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT (2015). Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis, 61(8), 1217-24. ()
    45. Siefkes H, Hamele M, Ampofo K, Poss WB (2015). Risk factors for poor outcomes and therapeutic strategies for seasonal and pandemic influenza. J Pediatr Intensive Care, 3(4), 217-226. ()
    46. Stockmann C, Ampofo K, Hersh A, Blaschke A, Kendall B, Korgenski K, Byington C, Pavia A (2012). Evolving Epidemiology of Invasive Group A Streptococcal Disease in Utah, 2002 – 2010. Clin Infect Dis.
    47. Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2012). The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J, 31(3), 228-34. ()
    48. Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J, 30(12), 1100-3. ()
    49. Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. Pediatr Infect Dis J. ()
    50. Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6. ()
    51. Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K (2011). Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. Clin Ther, 33(11), 1844-50. ()
    52. Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland JG (2011). Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J, 30(10), 895-7. ()
    53. Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield BA (2011). A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol, 46(10), 987-90. ()
    54. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K (2011). Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J, 30(4), 289-94. ()
    55. Ekstrand JJ, Herbener A, Rawlings J, Turney B, Ampofo K, Korgenski EK, Bonkowsky JL (2010). Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol, 68(5), 762-6. ()
    56. Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia AT (2010). Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J, 29(10), 905-9. ()
    57. Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia AT (2010). Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J, 29(8), 712-6. ()
    58. Zobell JT, Ampofo K, Cash J, Korgenski K, Chatfield BA (2010). High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. J Cyst Fibros, 9(4), 280-3. ()
    59. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO (2010). Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol, 48(2), 520-5. ()
    60. Bender JM, Ampofo K, Gesteland P, Sheng X, Korgenski K, Raines B, Daly JA, Valentine K, Srivastava R, Pavia AT, Byington CL (2010). Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J, 29(1), 6-9. ()
    61. Bender JM, Ampofo K, Gesteland P, Stoddard GJ, Nelson D, Byington CL, Pavia AT, Srivastava R (2009). Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care, 25(6), 369-75. ()
    62. She RC, Simmon KE, Bender JM, Ampofo K, Petti CA (2009). Mollicute infections in neonates. Pediatr Infect Dis J, 28(3), 248-50. ()
    63. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL (2009). Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis, 15(1), 44-8. ()
    64. Byington CL, Bender JM, Ampofo K, Pavia AT, Korgenski K, Daly J, Christenson JC, Adderson E (2008). Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis, 47(1), e4-6. ()
    65. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL (2008). Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis, 46(9), 1346-52. ()
    66. Blaschke AJ, Bender J, Byington CL, Korgenski K, Daly J, Petti CA, Pavia AT, Ampofo K (2007). Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing. Clin Infect Dis, 45(4), 483-6. ()
    67. Ampofo K, Byington C (2007). Management of parapneumonic empyema. Pediatr Infect Dis J, 26(5), 445-6. ()
    68. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO (2006). Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J, 25(3), 250-4. ()
    69. Gupta A, Ampofo K, Rubenstein D, Saiman L (2003). Extended spectrum beta lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol, 23(6), 439-43. ()
    70. Graham PL, Ampofo K, Saiman L (2002). Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J, 21(8), 798-800. ()
    71. Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A (2002). Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis, 34(6), 774-9. ()
    72. Ampofo KK, Saiman L (2002). Pediatric tuberculosis. Pediatr Ann, 31(2), 98-108. ()
    73. Ampofo K, Graham P, Ratner A, Rajagopalan L, Della-Latta P, Saiman L (2001). Plesiomonas shigelloides sepsis and splenic abscess in an adolescent with sickle-cell disease. Pediatr Infect Dis J, 20(12), 1178-9. ()

    Case Report

    1. Olarte L, Ampofo K, Thorell EA, Sanderson S, Doby E, Pavia AT, Rosado H, Raoult D, Socolovschi C, Hersh AL (2012). Bartonella vinsonii Endocarditis in an Adolescent with Congenital Heart Disease. Pediatr Infect Dis J, 31(3), 228.

    Letter

    1. Byington CL, Ampofo K, Korgenski K, Daly J, Pavia AT (2006). Empyema and Viral Illness in UT [Letter to the editor]. Pediatr Infect Dis, 25(9), 854.

  • Clinical Trials